Literature DB >> 6421734

Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

D P Speert, F Eftekhar, M L Puterman.   

Abstract

Pseudomonas aeruginosa is the predominant respiratory pathogen in patients with cystic fibrosis, but its mechanism of persisting in pulmonary secretions is poorly understood. We observed that three nonmucoid cystic fibrosis P. aeruginosa strains were phagocytized and one strain resisted phagocytosis by human polymorphonuclear leukocytes in the absence of serum. Phagocytosis was assessed by luminol-enhanced chemiluminescence, inspection of stained smears, bactericidal assay, reduction of nitroblue tetrazolium dye, and electron microscopy. Phagocytosis, determined by visual inspection, occurred at 35 degrees C but not at 4 degrees C. Nonopsonic phagocytosis was inhibited most efficiently by D-mannose, mannose-containing saccharides, and D-fructose. Opsonin-dependent phagocytosis of P. aeruginosa and of zymosan was not markedly inhibited by mannose, suggesting different leukocyte receptors for nonopsonic and opsonic phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421734      PMCID: PMC264285          DOI: 10.1128/iai.43.3.1006-1011.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Purification of the galactose-binding hemagglutinin of Pseudomonas aeruginosa by affinity column chromatography using sepharose.

Authors:  N Gilboa-Garber; L Mizrahi; N Garber
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

2.  Surface appendages similar to fimbriae (pili) on pseudomonas species.

Authors:  J A Fuerst; A C Hayward
Journal:  J Gen Microbiol       Date:  1969-10

Review 3.  Phagocytosis of microorganisms.

Authors:  M A Horwitz
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

4.  Structure of polar pili from Pseudomonas aeruginosa strains K and O.

Authors:  W Folkhard; D A Marvin; T H Watts; W Paranchych
Journal:  J Mol Biol       Date:  1981-06-15       Impact factor: 5.469

5.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

6.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Effect of pili on susceptibility of Escherichia coli to phagocytosis.

Authors:  F J Silverblatt; J S Dreyer; S Schauer
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Mannose-binding hemagglutinins in extracts of Pseudomonas aeruginosa.

Authors:  N Gilboa-Garber; L Mizrahi; N Garber
Journal:  Can J Biochem       Date:  1977-09

9.  Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.

Authors:  D E Woods; D C Straus; W G Johanson; J A Bass
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

10.  Interactions of Neisseria gonorrhoeae with human neutrophils: effects of serum and gonococcal opacity on phagocyte killing and chemiluminescence.

Authors:  R F Rest; S H Fischer; Z Z Ingham; J F Jones
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more
  36 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.

Authors:  D P Speert; L Thorson
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein.

Authors:  P A Sokol; D E Woods
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F.

Authors:  R E Hancock; L M Mutharia; E C Mouat
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.

Authors:  J L Battershill; D P Speert; R E Hancock
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum.

Authors:  E Mahenthiralingam; D P Speert
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose.

Authors:  D P Speert; S Gordon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.